亚洲子宫内膜异位症和子宫腺肌病学会子宫腺肌病管理指南
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis.
作者信息
Harada Tasuku, Taniguchi Fuminori, Guo Sun-Wei, Choi Young Min, Biberoglu Kutay Omer, Tsai Shaw-Jenq Sean, Alborzi Saeed, Al-Jefout Moamar, Chalermchokcharoenkit Amphan, Sison-Aguilar Angela G, Fong Yoke-Fai, Senanayake Hemantha, Popov Alexander, Hestiantoro Andon, Kaufman Yuval
机构信息
Faculty of Medicine, Tottori University Yonago Japan.
OB/GYN Hospital Fudan University Shanghai China.
出版信息
Reprod Med Biol. 2023 Sep 10;22(1):e12535. doi: 10.1002/rmb2.12535. eCollection 2023 Jan-Dec.
Abstract
This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.
摘要
这是亚洲子宫内膜异位症和子宫腺肌病学会发布的首份子宫腺肌病指南。
相似文献
1
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis.亚洲子宫内膜异位症和子宫腺肌病学会子宫腺肌病管理指南
Reprod Med Biol. 2023 Sep 10;22(1):e12535. doi: 10.1002/rmb2.12535. eCollection 2023 Jan-Dec.
2
Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study.制定关于保留子宫的子宫腺肌病治疗研究的核心结局集和结局定义（COSAR）：一项国际多利益相关者改良 Delphi 共识研究。
Hum Reprod. 2022 Aug 25;37(9):2012-2031. doi: 10.1093/humrep/deac166.
3
COMT 158G/A and CYP1B1 432C/G polymorphisms increase the risk of endometriosis and adenomyosis: a meta-analysis.儿茶酚-O-甲基转移酶158G/A和细胞色素P450 1B1 432C/G基因多态性增加子宫内膜异位症和子宫腺肌病的风险：一项荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:17-21. doi: 10.1016/j.ejogrb.2014.04.039. Epub 2014 May 13.
4
Ultrasound diagnosis of endometriosis and adenomyosis: State of the art.子宫内膜异位症和子宫腺肌病的超声诊断：现状。
Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:16-24. doi: 10.1016/j.bpobgyn.2018.01.013. Epub 2018 Feb 14.
5
Migraine Is More Prevalent in Advanced-Stage Endometriosis, Especially When Co-Occuring with Adenomoysis.子宫内膜异位症晚期患者偏头痛更为常见，尤其是当合并腺肌病时。
Front Endocrinol (Lausanne). 2022 Jan 24;12:814474. doi: 10.3389/fendo.2021.814474. eCollection 2021.
6
Catechol-O-methyltransferase 158G/A polymorphism and endometriosis/adenomyosis susceptibility: A meta-analysis in the Chinese population.儿茶酚-O-甲基转移酶158G/A多态性与子宫内膜异位症/子宫腺肌病易感性：中国人群的荟萃分析
J Cancer Res Ther. 2018 Dec;14(Supplement):S980-S984. doi: 10.4103/0973-1482.188439.
7
Patients' and relatives' perspectives on best possible care in the context of developing a multidisciplinary center for endometriosis and adenomyosis: findings from a national survey.患者和亲属对建立子宫内膜异位症和子宫腺肌病多学科中心的最佳可能护理的看法：一项全国性调查的结果。
BMC Womens Health. 2022 Jun 10;22(1):219. doi: 10.1186/s12905-022-01798-8.
8
Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis.子宫腺肌病和子宫内膜异位症患者的生殖、产科和围产期结局：系统评价和荟萃分析。
Hum Reprod Update. 2019 Sep 11;25(5):592-632. doi: 10.1093/humupd/dmz012.
9
Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional study.用于检测子宫内膜异位症和子宫腺肌病的血液生物标志物的多中心评估：一项前瞻性非干预性研究。
Int J Gynaecol Obstet. 2024 Jan;164(1):305-314. doi: 10.1002/ijgo.15062. Epub 2023 Aug 28.
10
[Comparative study of HLA-DQA1 and HLA-DRB1 allele in patients with endometriosis and adenomyosis].[子宫内膜异位症和子宫腺肌病患者中HLA - DQA1和HLA - DRB1等位基因的比较研究]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Feb;19(1):49-51.
引用本文的文献
1
Risk factors and countermeasures for abnormal uterine bleeding during dienogest therapy for adenomyosis: a review.地诺孕素治疗子宫腺肌病期间异常子宫出血的危险因素及对策：综述
Front Reprod Health. 2025 Jun 30;7:1550814. doi: 10.3389/frph.2025.1550814. eCollection 2025.
2
Uterine anteroposterior diameter predicts spontaneous pregnancy outcomes in women under 35 years with adenomyosis: a retrospective study.子宫前后径可预测35岁以下子宫腺肌病患者的自然妊娠结局：一项回顾性研究。
BMC Pregnancy Childbirth. 2025 Jul 4;25(1):727. doi: 10.1186/s12884-025-07828-1.
3
Improved surgical outcomes in adenomyosis: a novel insight into the superiority of secretory phase adenomyomectomy.子宫腺肌病手术效果的改善：对分泌期子宫腺肌瘤切除术优势的新见解。
Arch Gynecol Obstet. 2025 Jun 20. doi: 10.1007/s00404-025-08084-6.
4
Prognostic factors of progesterone resistance in symptomatic adenomyosis: impact of lesion localization on treatment outcome of levonorgestrel intrauterine system.症状性子宫腺肌病中孕激素抵抗的预后因素：病变部位对左炔诺孕酮宫内节育系统治疗效果的影响
BMC Womens Health. 2025 Jun 13;25(1):286. doi: 10.1186/s12905-025-03817-w.
5
Endometriosis Severity and Risk of Preeclampsia: A Combined Mendelian Randomization and Observational Study.子宫内膜异位症的严重程度与子痫前期风险：一项孟德尔随机化与观察性研究的联合分析
Int J Womens Health. 2025 Mar 27;17:923-935. doi: 10.2147/IJWH.S508174. eCollection 2025.
6
Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society.子宫腺肌病管理专家共识：台湾子宫内膜异位症学会采用改良德尔菲法
Gynecol Minim Invasive Ther. 2025 Feb 27;14(1):24-32. doi: 10.4103/gmit.GMIT-D-24-00055. eCollection 2025 Jan-Mar.
7
The present adenomyosis treatment status in Luzhou, China: a small scope observational cross-sectional survey.中国泸州目前的子宫腺肌病治疗现状：一项小范围观察性横断面调查。
BMC Womens Health. 2025 Feb 28;25(1):92. doi: 10.1186/s12905-025-03619-0.
8
Medical treatment before in-vitro fertilization in patients with adenomyosis: a systematic review and meta-analysis.子宫腺肌病患者体外受精前的医学治疗：系统评价与荟萃分析。
J Assist Reprod Genet. 2025 Feb;42(2):381-388. doi: 10.1007/s10815-024-03323-2. Epub 2024 Dec 12.
9
Adenomyosis-A Call for Awareness, Early Detection, and Effective Treatment Strategies: A Narrative Review.子宫腺肌病——呼吁提高认识、早期检测及有效的治疗策略：一篇叙述性综述
Healthcare (Basel). 2024 Aug 17;12(16):1641. doi: 10.3390/healthcare12161641.
10
MRI-Based Radiomics as a Promising Noninvasive Diagnostic Technique for Adenomyosis.基于磁共振成像的放射组学作为子宫腺肌病一种有前景的非侵入性诊断技术。
J Clin Med. 2024 Apr 18;13(8):2344. doi: 10.3390/jcm13082344.
本文引用的文献
1
In Search of an Imaging Classification of Adenomyosis: A Role for Elastography?探寻子宫腺肌病的影像学分类：弹性成像的作用？
J Clin Med. 2022 Dec 30;12(1):287. doi: 10.3390/jcm12010287.
2
Uterine Artery Embolization for Symptomatic Adenomyosis: Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel.子宫动脉栓塞术治疗症状性子宫腺肌病：来自介入放射学基金会研究共识小组的会议记录。
J Vasc Interv Radiol. 2022 May;33(5):586-592. doi: 10.1016/j.jvir.2022.01.017.
3
Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.促性腺激素释放激素激动剂下调联合激素替代疗法可改善高龄不明原因复发性种植失败患者冻融胚胎移植周期的妊娠结局。
Reprod Biol Endocrinol. 2022 Feb 3;20(1):26. doi: 10.1186/s12958-022-00897-3.
4
Cystic adenomyoma surgery.囊性腺肌瘤切除术。
J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102313. doi: 10.1016/j.jogoh.2022.102313. Epub 2022 Jan 11.
5
Heat can treat: long-term follow-up results after uterine-sparing treatment of adenomyosis with radiofrequency thermal ablation in 60 hysterectomy candidate patients.热疗治疗：60 例子宫切除术候选患者子宫腺肌病射频热消融保宫治疗的长期随访结果。
Surg Endosc. 2022 Aug;36(8):5803-5811. doi: 10.1007/s00464-021-08984-z. Epub 2022 Jan 13.
6
The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis.子宫腺肌病对体外受精结局的影响：一项系统评价和荟萃分析。
Reprod Sci. 2022 Nov;29(11):3177-3193. doi: 10.1007/s43032-021-00818-6. Epub 2022 Jan 3.
7
Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis.冻融胚胎移植前长期 GnRH 激动剂预处理可改善子宫腺肌病患者的妊娠结局。
Reprod Biomed Online. 2022 Feb;44(2):380-388. doi: 10.1016/j.rbmo.2021.10.014. Epub 2021 Oct 25.
8
Classifying Adenomyosis: Progress and Challenges.子宫腺肌病的分类：进展与挑战
Int J Environ Res Public Health. 2021 Nov 25;18(23):12386. doi: 10.3390/ijerph182312386.
9
Ultrasound-guided percutaneous microwave ablation of adenomyosis: a narrative review.超声引导下经皮微波消融治疗子宫腺肌病：叙述性综述。
Ann Palliat Med. 2021 Nov;10(11):12003-12011. doi: 10.21037/apm-21-3133.
10
A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis.一项比较高效孕激素、左炔诺孕酮宫内缓释系统（LNG-IUS）和地诺孕素治疗子宫腺肌病女性的对照临床试验。
Reprod Med Biol. 2021 Sep 7;20(4):427-434. doi: 10.1002/rmb2.12408. eCollection 2021 Oct.
Zotero 插件